Affect Therapeutics delivers an evidence-based digital care program designed specifically for individuals suffering from stimulant use disorder. The program includes a digital therapeutic smartphone app coupled with telemedicine-based addiction counseling, drug screening, group therapy, and psychiatric support.
Founded
2020
Invested
2021
Affect Therapeutics
Health
Founded
2020
Invested
2021
Founders
Kristin Muhlner, Jeff De Flavio, and Rachel Lin